00:00 – Dr. Hlavinka: But again, in a symptomatic patient when I’ve got the choice between traditional cultures, which I
00:05 – know are going to be a fail, and NGS, I’m going to pick the one that’s going to give me more accurate information
00:24 – Melissa: Let’s talk a little bit more about testing. Can you first explain to us why standard
00:28 – urine culture is inadequate, especially for recurrent UTI?
00:37 – Dr. Hlavinka: Can I, boy can I. Yes I can. I got introduced to next generation sequencing DNA testing three and a half years ago
00:46 – when I was particularly frustrated with a group of my complicated UTI patients and not being able to
00:52 – find answers. I had had the lab throw out a total of seven cultures on a single patient despite the
01:00 – fact that I even called up the head pathologist and asked for special handling of it, to get me
01:06 – an answer. And they just they simply can’t do it. Everything is automated, there’s just no way
01:12 – to change the limitations of traditional cultures. So let’s go back to high school
01:17 – biology when you first dealt with the petri dish. And you had the little petri dish and had
01:21 – a little agar plate on it, which is food for the bacteria, and you coughed in your hand and you took
01:27 – your swab, your cotton swab and you swabbed it on the little agar plate. You waited two days and
01:33 – you watched it grow and said, oh that’s great, look at that! Look, there’s bacteria growing and there’s
01:36 – different kinds. And you have little colonies, little dots grow up. Little white or pink dots
01:40 – grow up. And then they gave you something called penicillin and it looked like a little, you know
01:46 – tab you put on to stop your bleeding, or your you know, something like that little paper tab.
01:50 – And you put that on there and it’s penicillin, and then two days later you saw the bacteria
01:54 – get killed by it. And that’s that is how Robert Koch in Germany in 1848 invented cultures. And
02:01 – there has literally been no significant change in the technology, other than to automate it,
02:09 – since then. And the automation has made it worse, as I said earlier, because it simply makes it where
02:14 – human beings don’t intervene. So the capacity to identify multiple organisms to sub species,
02:21 – to create different time frames for looking at the plates and finding out what’s growing, that
02:27 – just doesn’t exist anymore. And so you’re left with what the lab gives you. And you could be charged
02:32 – anywhere from in the United States 48 dollars for a negative culture, to 140 that has multiple
02:39 – organisms that need to be sub-speciated. And when you look at next generation sequencing costs it’s
02:45 – not cheap compared to that but it definitely gives you more information. So that is what the
02:51 – standard urine culture does. And it must be done within two hours, it must be sent within two hours or else.
02:58 – Melissa: Which must never happen.
03:01 – Dr. Hlavinka: Right, exactly. You typically have to do a special technique to prep yourself, where you have skin contaminants that make them throw it out.
03:11 – And if you use too much of the little soaps it can kill bacteria so it’s very difficult to get
03:16 – it right. It also has a limitation into the time frame that you can get results back. Again, now
03:24 – next generation sequencing is getting back pretty quickly such that that’s no longer an issue. And
03:30 – in some places, in the urinary tract infections realm, up to 70% (of cultures) were in error.
03:37 – Maybe even higher numbers were in error, meaning they didn’t find an organism that was there, or
03:42 – they found organisms that weren’t there, that they found, that really weren’t pathogens
03:48 – and were contaminants. Now that is a problem with next generation sequencing too, it is not with PCR,
03:54 – but PCR has the fault of not being able to find something it’s not looking for. Let’s look
03:58 – at polymerase chain reaction or PCR. So PCR is, it’s called polymerase chain reaction and what that’s
04:07 – looking for is amplification of a genetic signal. You can either use RNA, like they’re doing for
04:14 – the Coronavirus or you can use DNA like we do for most microbes. And you take a little piece of the
04:20 – DNA – a piece of the genetic code – and you have a machine that amplifies it big time and fast,
04:26 – so you can get a read on it. You’re going to get an identification and you can get an estimation of
04:32 – the number of microorganisms by the amount of genetic material that’s there. So you can
04:37 – identify it and predict how much is there by that, and that’s what PCR can do, But PCR is a probe,
04:46 – meaning it only looks, I should say, it only finds what it looks for. And if that sounds glib
04:51 – it’s not, because let’s use the analogy of a lego detector right. Let’s say you’ve got a box with,
04:58 – you know, 28000 legos in it. All right. Each of them individual. And you know that your lego is a cube
05:06 – with three prongs, right, that’s two centimeters by two centimeters. So what PCR does is it goes
05:13 – in there and it looks for that exact lego. If it doesn’t find that exact lego, if it’s two by three,
05:19 – it says ‘nothing there guys, nothing to be worried about’, pull out and no lego searching anymore.
05:25 – What next generation sequencing does is it goes in and it says ‘ah oh there’s a peg, okay okay,
05:32 – there’s a side that’s two centimeters, oh there’s another side, there’s a third side okay, it’s a cube.
05:38 – Oh there’s a second peg, there’s a third peg, bingo! E. coli’. And it pulls out the two by two by two
05:44 – three prong lego. And so that is why NGS is so unique and so valuable. It’s just going to find
05:51 – that that two by two by two three prong lego 99.4 percent of the time accurately, all right.
06:00 – And that’s so important to recognize. Now maybe that particular lego isn’t causing your infection,
06:06 – but at least you know it’s there and that’s what I think is the most important. And if you’ve
06:11 – got that lego in there, and you know, you’ve got nine million of them, well then you know that you’ve
06:18 – got a problem, all right. And that’s the other thing, so NGS can also give you an estimation
06:23 – of the bacterial load, the microbial load, like PCR can but it’s much more accurate at identifying
06:30 – precisely the organisms that are there.
06:33 – Melissa: So when it comes to treatment using this kind of technology, is it the bacterial load that really tells you whether
06:38 – something should be treated, or is it the fact that it’s a known pathogen?
06:44 – Dr. Hlavinka: That is a very, very good question and just, oh my gosh, there are people that people that want to pay me to give them that answer.
06:54 – And the answer to that is, after doing this for three and a half years with over 800 specimens,
07:00 – the answer is yes. And I’m not again being glib, but the answer is that a known pathogen
07:08 – in a symptomatic patient with a low bacterial load – I’m going to be cautious and I’m going to treat. And
07:16 – I’m going to do that because if they’re having symptoms, if they’re having symptoms now, you know
07:21 – a little bit of urinary frequency, and it’s a two percent read of E. coli maybe not, but if burning,
07:28 – frequency every 15 minutes, low grade fever, feel terrible, yes I’m going to treat that, because I may
07:33 – have an infection that I failed to treat adequately. On the other hand, if you have a really high load
07:40 – of something that’s a known contaminant or a known commensal organism – commensal means
07:47 – an organism that normally lives on the body in an unpathogenic way, in a non-infectious way – then
07:53 – I might ignore that, but if they’re symptomatic and that’s the only thing that the NGS gave me,
07:59 – I will treat that too. And so you can see that – I’ve seen that with Gardnerella in
08:04 – the bladder in women, with Lactobacillus in the bladder, with women where nothing else is there.
08:09 – It’s not a contaminant. There’s a high read, high load and I treat them and they get better.
08:16 – Melissa: That’s interesting. And one question that we get a lot – I’m not sure if you can answer it – but how do
08:20 – you know that the DNA found using this technology is alive, or represented something that was alive?
08:27 – Dr. Hlavinka: You don’t. You don’t. And again, I deal with symptoms. And the fact is, is that
08:32 – I know that this technology is superior, so the bottom line is that there are there are downsides
08:39 – of NGS and that could be one of them. But again, in a symptomatic patient when I’ve got the choice
08:45 – between traditional cultures which I know are going to be a fail, and NGS which may give me some
08:50 – false information based on non-viable nucleic acid, I’m going to pick the one that’s going to give me more accurate information.
08:57 – Melissa: So we do see that it’s not exactly standard for clinicians to use
09:03 – this kind of technology for bladder infection, and someone sent in a question that’s very relevant
09:07 – for 2020, which is why are clinicians so willing to use this technology for something like COVID-19,
09:13 – but they are not willing to use it for infection in the bladder?
09:17 – Dr. Hlavinka: That’s a very good question and if I had the answer, I would have the answer to why clinicians do what they do on a daily basis.
09:25 – I give the example of a stethoscope. Stethoscope is basically the same it’s been for 150 years,
09:32 – just like urine cultures and we haven’t really made that many improvements in it. What if somebody
09:39 – invented a chip that you put in a stethoscope that made your diagnostic listening to the heart sounds
09:47 – and lung sounds just 98.97% more accurate and you can’t screw it up. You know you’re going to get,
09:55 – and it’ll give you a readout and show you, oh my gosh, you have that S2 sound in the heart, or
10:01 – you’ve got a gallop sound, or you’ve got a murmur and you missed a murmur. What would happen to
10:06 – stethoscope sales, all right? Old ones would go away, no one would buy them, they would be historically in
10:13 – museums and there’d be a run on stores to get the newest type of stethoscope. So I don’t understand
10:19 – why my colleagues will not incorporate this. It’s not that hard. It took three months of doing dual
10:26 – cultures and next generation sequencing. When I started this, Melissa, I didn’t know anything
10:30 – about PCR even. So I kind of got PCR and NGS at the same time, which was good for me because then I
10:37 – saw the limitations and benefits of both. But I can certainly tell you that the limitations
10:42 – of traditional cultures are vast and leaving behind traditional cultures for newer technologies
10:50 – is absolutely essential. It is not just state-of-the-art, it’s standard of care, and providers that don’t
10:57 – incorporate this into their practice are not practicing state-of-the-art medicine. And I will
11:01 – say that to their face. You can pass this on to them if they need more education about it and
11:07 – its benefits. Send them my email, give them my cell phone. I’ll be glad to talk to them.
11:13 – Melissa: I may do that. We actually receive a lot of emails from people who have been diagnosed with Interstitial Cystitis
11:18 – based on negative urine culture even though they have symptoms that are very similar to UTI.
11:23 – In that case would you say that those people may benefit from pursuing testing with different technology?
11:29 – Dr. Hlavinka: Absolutel. I’m glad you got into that subject because once again we
11:35 – are looking at a new technology. And maybe that news type of stethoscope tells us about sounds
11:40 – that we never were capable of hearing before, and we have to invent brand new markers and brand new
11:46 – designations and brand new heart sounds and all that because we didn’t know what we didn’t know.
11:50 – Same thing with next generation sequencing. So we don’t really know what an infection eradication
11:58 – is, to go back to the testing just briefly. Because if I get just a little bit of E. coli and I’ve
12:03 – treated you and have no symptoms, you haven’t had symptoms for a month well I’m not going to
12:06 – chase that. So the negative culture is useless, but do we chase a negative PCR or NGS?
12:15 – I don’t think so. But again, the playing field is changing. These are things that are evolving.
12:20 – The same thing with the question that you ask is I don’t ever assume that an infection is not a part
12:27 – of the patient’s symptoms until I have a negative NGS. And clearly that doesn’t mean for
12:34 – you know, simple things like passing a kidney stone, which I do in urology. But even then that they can
12:40 – have an infection that’s missed because the stones blocking and we get a little bit of the bacteria
12:43 – beyond the stone. But the bottom line is for things like IC, chronic pelvic pain, chronic prostatitis,
12:50 – pain on intercourse, pain with ejaculation, pain, all these things, I never assume there’s not an
12:57 – infection unless I have a negative NGS. That’s way too many double negatives, but you get the point.
13:04 – But again, it is changing the playing field for what I see is fully 50% of my IC patients and
13:10 – probably more than 50%. I would say probably the majority, probably 55% of my IC patients
13:17 – have a detectable, significant load organism that I treat and improve symptoms. In many of them
13:24 – it’s allowed me to take them off medication. It was the problem all along, all right. Now some of
13:29 – them that fail, I scope and then we do the ulcer check and things like that. But the bottom line is
13:34 – that until you do an NGS and whether or not it’s catheterized or voided, that’s a controversy too, but until
13:41 – you do an NGS and it’s negative I don’t call it IC anymore. And I believe those criteria should change soon.
13:46 – Melissa: That was going to be the next question: If you have had patients with previously diagnosed
13:52 – IC that have been found to have infection and have subsequently been treated and symptoms have resolved.
13:59 – Dr. Hlavinka: Yes, the answer is yes.
14:02 – Melissa: One final question on the testing is, do you think it’s important to test both the vagina and the urinary tract when there’s chronic UTI symptoms?
14:10 – Dr. Hlavinka: Yes, there’s never a good doctor who won’t take more information. Now what
14:16 – we do with it is different, it may be different, but there’s never a good doctor that won’t take
14:21 – more information. And I love information and this has given me information I never had before.
Key Take Aways
Traditional Urine Cultures Consistently Fail
Polymerase Chain Reaction Limits Targets
Genomic Sequencing Uncovers Hidden Pathogens
Symptom Severity Guides Treatment Decisions
Genomic Testing Redefines Interstitial Cystitis
Molecular Testing Improves Clinical Outcomes

Stay up to date with our latest videos, interviews, insights, and musings from the Live UTI Team





Interviews, insights, and musings from the Live UTI Team, and Industry Professionals.



